Efficacy of a Brief Nightmare Treatment for Veterans

This study has been completed.
Sponsor:
Information provided by:
University of Tulsa
ClinicalTrials.gov Identifier:
NCT01220401
First received: October 11, 2010
Last updated: August 3, 2011
Last verified: August 2011

October 11, 2010
August 3, 2011
October 2010
August 2011   (final data collection date for primary outcome measure)
  • Trauma Related Nightmare Scale [ Time Frame: pre, one week, two months ] [ Designated as safety issue: No ]
    measures will be given pre treatment, one week and two months following treatment completion.
  • Clinician Administered PTSD Scale [ Time Frame: pre, one week, two months ] [ Designated as safety issue: No ]
    measures will be given pre treatment, one week and two months following treatment completion.
Same as current
Complete list of historical versions of study NCT01220401 on ClinicalTrials.gov Archive Site
Suicide Behaviors Questionnaire [ Time Frame: pre, one week, two months post ] [ Designated as safety issue: No ]
measures will be given pre treatment, one week and two months following treatment completion.
Same as current
Not Provided
Not Provided
 
Efficacy of a Brief Nightmare Treatment for Veterans
Efficacy of a Brief Nightmare Treatment for Veterans

The purpose of this study is to find out what effects Exposure, Rescripting, and Relaxation Therapy (ERRT) has on nightmares and associated problems in veterans.

The purpose of the proposed pilot study is to extend previous findings regarding the impact of a brief cognitive behavioral treatment for chronic nightmares by examining the emotional, cognitive, behavioral, and health-related changes following treatment. Experiencing a traumatic event may initiate or exacerbate the occurrence of nightmares. Indeed, sleep disturbance, including nightmares, is considered a hallmark of posttraumatic stress disorder (PTSD). Nightmares have been related to a variety of factors including stress, medications, trauma, and substance use. Among veterans, especially combat veterans or those reporting sexual assaults, symptoms of traumatic stress and nightmares are extremely common. Few studies have investigated the efficacy of nightmare treatment in a veteran population, and the impact of nightmare treatment on suicidal ideation has never been assessed.

Imagery Rehearsal Treatment (IRT) has received increased attention in the past decade for use with chronic nightmares. Studies suggest that the treatment is promising for the reduction of frequency and intensity of chronic nightmares in trauma exposed persons and may have a generalized impact on symptoms of posttraumatic stress disorder and depression and quality/quantity of sleep, although there is mixed evidence for sleep improvement among veterans. The principal investigator has completed two randomized controlled trials of a modified version of IRT, Exposure, Rescripting, and Relaxation Treatment (ERRT) and is currently conducting a third randomized controlled trial (Davis, 2008; Davis & Wright, 2007). The current randomized controlled trial is comparing ERRT to an active treatment (relaxation). Results demonstrated positive treatment response. Although these trials have included some veteran participants, veterans have not been studied as a group using this protocol. The purpose of this prospective study is to conduct a pre- and post-treatment comparison of suicidal ideation and posttraumatic, depressive, and health symptoms in a single group of veterans.

Interventional
Not Provided
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Sleep Disorders
  • PTSD
  • Suicide
Behavioral: exposure, relaxation, and rescription therapy
veterans reporting chronic nightmares at least once per week for the past month who consent to participate will attend four consecutive weekly sessions lasting approximately two hours each. Participants will log their sleep events and associated symptoms (i.e. PTSD, depression, etc.)
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
August 2011
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria: veteran/military, 18+ years old, english proficiency, nightmares once per week, exposure to a criterion A traumatic event -

Exclusion Criteria: under 18, psychotic illness, mental retardation, imminent suicidal intent

-

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01220401
TU1107
No
Noelle Balliett, The University of Tulsa
University of Tulsa
Not Provided
Principal Investigator: Noelle Balliett, MA The University of Tulsa
University of Tulsa
August 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP